◀ Back to ABL1
ABL1 — FLT3
Text-mined interactions from Literome
Okuda et al., Blood 2001
(Cell Transformation, Neoplastic) :
In addition to BCR/ABL, STI571 also inhibits v-Abl,
TEL/ABL , the native platelet derived growth factor ( PDGF ) beta receptor, and c-KIT, but it does not
inhibit SRC family kinases, c-FMS,
FLT3 , the epidermal growth factor receptor, or multiple other tyrosine kinases
Giles et al., Curr Mol Med 2005
(Hematologic Neoplasms...) :
FLT3 , VEGF, and
BCR-ABL mediate their activities via mTOR